NATALIE MACDONALD: Open Payments
NPI 1730429994 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,459 in 133 payments from 21 companies in 2025. Trend: 2023 $2,282 · 2024 $2,510 · 2025 $2,459
Food & beverage: $2,459
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $307 |
| PFIZER INC. | 14 | $235 |
| AstraZeneca Pharmaceuticals LP | 9 | $232 |
| Novo Nordisk Inc | 15 | $215 |
| Lilly USA, LLC | 8 | $157 |
| GlaxoSmithKline, LLC. | 7 | $148 |
| Axsome Therapeutics, Inc. | 5 | $143 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $136 |
| Dexcom, Inc. | 6 | $120 |
| Amgen Inc. | 7 | $116 |
Products named: MOUNJARO, Auvelity, Ozempic, Kerendia, TRELEGY ELLIPTA, AIRSUPRA, Dexcom G6 Transmitter, VRAYLAR.
Industry payments across IN — which companies pay providers there.
